LI Tingting,ZHOU Ganping,CHEN Yanqing,et al.Expert consensus on the implementation and management of drug selection for centralized volume-based procurement in medical institutions of Guangxi[J].ZHONGGUO YAOFANG,2026,37(07):829-834.
LI Tingting,ZHOU Ganping,CHEN Yanqing,et al.Expert consensus on the implementation and management of drug selection for centralized volume-based procurement in medical institutions of Guangxi[J].ZHONGGUO YAOFANG,2026,37(07):829-834.DOI: 10.6039/j.issn.1001-0408.2026.07.01.
Expert consensus on the implementation and management of drug selection for centralized volume-based procurement in medical institutions of Guangxi
Expert Consensus on the Implementation and Management of Drug Selection for Centralized Volume-Based Procurement in Medical Institutions of Guangxi
(hereinafter referred to as the “
Consensus
”), and to provide decision-making support and practical guidance for the drug selection and management of centralized volume-based procurement (hereinafter referred to as “centralized procurement”) drugs in medical institutions at all levels in Guangxi.
METHODS
2
A systematic review was conducted on the materials from previous batches of centralized procurement implemented in Guangxi. A comprehensive search was carried out for drug-related works and books, along with a systematic collation of guidelines on drug selection, expert consensus on centralized procurement, and policy documents. Through three rounds of specialized seminars, combined with existing evidence-based data and the practical drug selection experiences of medical institutions at various levels, this
Consensus
was formulated after thorough discussion and successive rounds of revision.
RESULTS CONCLUSIONS
2
The
Consensus
systematically outlines the three key stages in the implementation of centralized procurement in medical institutions: procurement volume reporting, confirmation of agreed procurement volume, and procurement and usage implementation. It proposes drug selection strategies for centralized procurement based on multiple dim
ensions, including specifications, dosage forms, packaging materials, fill volume, and manufacturing enterprises. In response to practical challenges encountered in the selection process, corresponding countermeasures are proposed, such as establishing a regularized information reserve mechanism, strengthening information technology support, and implementing categorized selection approaches. The
Consensus
advocates for medical institutions to construct an integrated “policy, data, and quality” decision-making system to promote full-cycle management of centralized procurement. This
Consensus
will provide scientific and practical guidance for medical institutions at all levels in Guangxi in the drug selection of centralized procurement, facilitating the smooth implementation and sustainable development of centralized procurement policies at the institutional level.
CHINA PH ARMACY Volume 33,Number 7,April 15,2022 Semimonthly Table of Contents Drug selection guideline for medical institutions
Evidence-based expert consensus on the clinical application and pharmaceutical management of antibody-based drugs for the treatment of myasthenia gravis
Expert consensus on clinical application of inhaled aminoglycoside antimicrobials in lower respiratory tract infections
Expert consensus on the clinical application of parenteral direct thrombin inhibitors in special populations
Expert consensus on clinical application of parenteral direct thrombin inhibitors in perioperative period
Related Author
LI Zhengxiang
ZHANG Yu
ZHANG Lingli
DUAN Rong
DUAN Rong
LI Zhengxiang
ZUO Xiaocong
ZHAO Rongsheng
Related Institution
Hebei Myasthenia Gravis Diagnosis and Treatment Center, Shijiazhuang People’s Hospital
Dept. of Pharmacy, the Second Hospital of Shanxi Medical University
Dept. of Pharmacy, Peking University Third Hospital
the Third Xiangya Hospital, Central South University
Tianjin Center for Drug Use Monitoring and Clinical Comprehensive Evaluation